This study was supported by a National Institute of Mental Health grant R34 MH10182 (to Drs. McGough and Loo, Co-PIs). Study devices and some materials were provided by NeuroSigma, Inc. in response to an investigator-initiated request.
Portions of this study were presented at the International Society for Child and Adolescent Psychopathology 19th Biennial Meeting; June 26-29, 2019; Los Angeles, California and the American Academy of Child and Adolescent Psychiatry 65th Annual Meeting; October 23-28, 2019; Chicago, Illinois.
Dr. Loo served as the statistical expert for this research.
Conceptualization: Loo, McGough
Data curation: Loo, Salgari, Ellis, Dillon
Formal analysis: Loo, Ellis
Funding acquisition: Loo, McGough
Investigation: Salgari, Cowen, McGough
Methodology: Loo, Cowen, McGough
Project administration: Cowen, Dillon, McGough
Writing – original draft: Loo
Writing – review and editing: Loo, Salgari, Ellis, Dillon, McGough
Disclosure: Dr. McGough has provided expert witness testimony for Eli Lilly and Co. and Tris Pharma and has received DSMB honoraria from Sunovion. Drs. Loo, Ellis, Cowen, Dillon and Ms. Salgari have reported no biomedical financial interests or potential conflicts of interest.
Clinical trial registration information: Developmental Pilot Study of External Trigeminal Nerve Stimulation for ADHD; http://clinicaltrials.gov; NCT02155608